| 000 | 02442 a2200673 4500 | ||
|---|---|---|---|
| 005 | 20250516063025.0 | ||
| 264 | 0 | _c20120507 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1873-7544 | ||
| 024 | 7 |
_a10.1016/j.neuroscience.2011.10.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChristianson, C A | |
| 245 | 0 | 0 |
_aSpinal matrix metalloproteinase 3 mediates inflammatory hyperalgesia via a tumor necrosis factor-dependent mechanism. _h[electronic resource] |
| 260 |
_bNeuroscience _cJan 2012 |
||
| 300 |
_a199-210 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 | _aCalcium-Binding Proteins |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 |
_aDipeptides _xtherapeutic use |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xmethods |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
| 650 | 0 | 4 |
_aHydroxamic Acids _xtherapeutic use |
| 650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
| 650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
| 650 | 0 | 4 |
_aInflammation _xchemically induced |
| 650 | 0 | 4 | _aLipopolysaccharides |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 3 _xadministration & dosage |
| 650 | 0 | 4 | _aMicrofilament Proteins |
| 650 | 0 | 4 |
_aNeuroglia _xdrug effects |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aPain Threshold _xdrug effects |
| 650 | 0 | 4 | _aPhysical Stimulation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReaction Time _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
| 650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factors _xmetabolism |
| 700 | 1 | _aFitzsimmons, B L | |
| 700 | 1 | _aShim, J-H | |
| 700 | 1 | _aAgrawal, A | |
| 700 | 1 | _aCohen, S M | |
| 700 | 1 | _aHua, X-Y | |
| 700 | 1 | _aYaksh, T L | |
| 773 | 0 |
_tNeuroscience _gvol. 200 _gp. 199-210 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2011.10.019 _zAvailable from publisher's website |
| 999 |
_c21286342 _d21286342 |
||